TYK2 is a key regulator of the surveillance of B lymphoid tumors.
Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, Sexl V.
Stoiber D, et al. Among authors: sexl v.
J Clin Invest. 2004 Dec;114(11):1650-8. doi: 10.1172/JCI22315.
J Clin Invest. 2004.
PMID: 15578097
Free PMC article.